• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蛋白激酶Cε的靶向破坏通过使头颈鳞状细胞癌中的RhoA和RhoC GTP酶失活来降低细胞侵袭和运动能力。

Targeted disruption of protein kinase C epsilon reduces cell invasion and motility through inactivation of RhoA and RhoC GTPases in head and neck squamous cell carcinoma.

作者信息

Pan Quintin, Bao Li Wei, Teknos Theodoros N, Merajver Sofia D

机构信息

Division of Hematology and Oncology, Department of Internal Medicine, Comprehensive Cancer Center, University of Michigan Health System, Ann Arbor, MI 48109, USA.

出版信息

Cancer Res. 2006 Oct 1;66(19):9379-84. doi: 10.1158/0008-5472.CAN-06-2646.

DOI:10.1158/0008-5472.CAN-06-2646
PMID:17018591
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4383316/
Abstract

Over 70% of patients with head and neck squamous cell carcinoma (HNSCC) present with locoregionally advanced stage III and IV disease. In spite of aggressive therapy, locoregional disease recurs in 60% and metastatic disease develops in 15% to 25% of patients causing a major decline in quality and length of life. Therefore, there is a need to identify and understand genes that are responsible for inducing an aggressive HNSCC phenotype. Evidence has shown that protein kinase C (PKC) epsilon is a transforming oncogene and may play a role in HNSCC progression. In this study, we determine the downstream signaling pathway mediated by PKC epsilon to promote an aggressive HNSCC phenotype. RNA interference knockdown of PKC epsilon in UMSCC11A and UMSCC36, two highly invasive and motile HNSCC cell lines with elevated endogenous PKC epsilon levels, resulted in cells that were significantly less invasive and motile than the small interfering RNA-scrambled control transfectants; 51 +/- 5% (P < 0.006) and 49 +/- 3% (P < 0.010) inhibition in invasion and 69 +/- 1% (P < 0.0005) and 66 +/- 3% (P < 0.0001) inhibition in motility, respectively. PKC epsilon-deficient UMSCC11A clones had reduced levels of active and serine-phosphorylated RhoA and RhoC. Moreover, constitutive active RhoA completely rescued the invasion and motility defect, whereas constitutive active RhoC completely rescued the invasion and partially rescued the motility defect of PKC epsilon-deficient UMSCC11A clones. These results indicate that RhoA and RhoC are downstream of PKC epsilon and critical for PKC epsilon-mediated cell invasion and motility. Our study shows, for the first time, that PKC epsilon is involved in a coordinated regulation of RhoA and RhoC activation, possibly through direct post-translational phosphorylation.

摘要

超过70%的头颈部鳞状细胞癌(HNSCC)患者就诊时已处于局部晚期III期和IV期疾病。尽管进行了积极治疗,但60%的患者局部疾病会复发,15%至25%的患者会发生转移性疾病,导致生活质量和寿命大幅下降。因此,有必要识别和了解导致侵袭性HNSCC表型的基因。有证据表明,蛋白激酶C(PKC)ε是一种转化癌基因,可能在HNSCC进展中起作用。在本研究中,我们确定了PKCε介导的下游信号通路,以促进侵袭性HNSCC表型。在UMSCC11A和UMSCC36这两种具有高侵袭性和运动性且内源性PKCε水平升高的HNSCC细胞系中,通过RNA干扰敲低PKCε,导致细胞的侵袭性和运动性明显低于小干扰RNA-乱序对照转染细胞;侵袭抑制率分别为51±5%(P<0.006)和49±3%(P<0.010),运动抑制率分别为69±1%(P<0.0005)和66±3%(P<0.0001)。PKCε缺陷的UMSCC11A克隆中活性和丝氨酸磷酸化的RhoA和RhoC水平降低。此外,组成型活性RhoA完全挽救了侵袭和运动缺陷,而组成型活性RhoC完全挽救了侵袭缺陷并部分挽救了PKCε缺陷的UMSCC11A克隆的运动缺陷。这些结果表明,RhoA和RhoC是PKCε的下游,对PKCε介导的细胞侵袭和运动至关重要。我们的研究首次表明,PKCε可能通过直接的翻译后磷酸化参与RhoA和RhoC激活的协调调节。

相似文献

1
Targeted disruption of protein kinase C epsilon reduces cell invasion and motility through inactivation of RhoA and RhoC GTPases in head and neck squamous cell carcinoma.蛋白激酶Cε的靶向破坏通过使头颈鳞状细胞癌中的RhoA和RhoC GTP酶失活来降低细胞侵袭和运动能力。
Cancer Res. 2006 Oct 1;66(19):9379-84. doi: 10.1158/0008-5472.CAN-06-2646.
2
Protein kinase C epsilon is a predictive biomarker of aggressive breast cancer and a validated target for RNA interference anticancer therapy.蛋白激酶Cε是侵袭性乳腺癌的一种预测性生物标志物,也是RNA干扰抗癌治疗的一个经过验证的靶点。
Cancer Res. 2005 Sep 15;65(18):8366-71. doi: 10.1158/0008-5472.CAN-05-0553.
3
Down regulation of RhoC by microRNA-138 results in de-activation of FAK, Src and Erk1/2 signaling pathway in head and neck squamous cell carcinoma.微小RNA-138对RhoC的下调导致头颈部鳞状细胞癌中粘着斑激酶、Src和Erk1/2信号通路失活。
Oral Oncol. 2014 May;50(5):448-56. doi: 10.1016/j.oraloncology.2014.01.014. Epub 2014 Feb 22.
4
RhoC mediates epidermal growth factor-stimulated migration and invasion in head and neck squamous cell carcinoma.RhoC 介导头颈部鳞状细胞癌中表皮生长因子刺激的迁移和侵袭。
Neoplasia. 2015 Jan;17(1):141-51. doi: 10.1016/j.neo.2014.12.002.
5
Characterization of the roles of RHOC and RHOA GTPases in invasion, motility, and matrix adhesion in inflammatory and aggressive breast cancers.鉴定 RHOC 和 RHOA GTPases 在炎症性和侵袭性乳腺癌的入侵、迁移和基质黏附中的作用。
Cancer. 2010 Jun 1;116(11 Suppl):2768-82. doi: 10.1002/cncr.25181.
6
Functional analysis of the contribution of RhoA and RhoC GTPases to invasive breast carcinoma.RhoA和RhoC GTP酶对浸润性乳腺癌作用的功能分析
Cancer Res. 2004 Dec 1;64(23):8694-701. doi: 10.1158/0008-5472.CAN-04-2247.
7
A novel strategy for specifically down-regulating individual Rho GTPase activity in tumor cells.一种在肿瘤细胞中特异性下调单个Rho GTP酶活性的新策略。
J Biol Chem. 2003 Nov 7;278(45):44617-25. doi: 10.1074/jbc.M308929200. Epub 2003 Aug 25.
8
RhoC regulates cancer stem cells in head and neck squamous cell carcinoma by overexpressing IL-6 and phosphorylation of STAT3.RhoC通过过度表达IL-6和STAT3磷酸化来调控头颈部鳞状细胞癌中的癌症干细胞。
PLoS One. 2014 Feb 12;9(2):e88527. doi: 10.1371/journal.pone.0088527. eCollection 2014.
9
Atorvastatin inhibits RhoC function and limits head and neck cancer metastasis.阿托伐他汀抑制 RhoC 功能并限制头颈部癌症转移。
Oral Oncol. 2013 Aug;49(8):778-86. doi: 10.1016/j.oraloncology.2013.04.003. Epub 2013 May 4.
10
RhoC expression and head and neck cancer metastasis.RhoC 表达与头颈部癌症转移。
Mol Cancer Res. 2009 Nov;7(11):1771-80. doi: 10.1158/1541-7786.MCR-08-0512. Epub 2009 Oct 27.

引用本文的文献

1
PI3K-dependent GAB1/Erk phosphorylation renders head and neck squamous cell carcinoma sensitive to PI3Kα inhibitors.PI3K 依赖的 GAB1/Erk 磷酸化使头颈部鳞状细胞癌对 PI3Kα 抑制剂敏感。
Cell Death Dis. 2025 Jun 18;16(1):457. doi: 10.1038/s41419-025-07767-x.
2
Cross talk of tumor protein D52 (TPD52) with KLF9, PKCε, and MicroRNA 223 in ovarian cancer.卵巢癌细胞中肿瘤蛋白 D52(TPD52)与 KLF9、PKCε 和 MicroRNA 223 的串扰。
J Ovarian Res. 2023 Oct 13;16(1):202. doi: 10.1186/s13048-023-01292-1.
3
Protein kinase C epsilon activation regulates proliferation, migration, and epithelial to mesenchymal-like transition in rat Schwann cells.蛋白激酶Cε激活调节大鼠雪旺细胞的增殖、迁移以及上皮向间充质样转变。
Front Cell Neurosci. 2023 Aug 14;17:1237479. doi: 10.3389/fncel.2023.1237479. eCollection 2023.
4
Protein Kinase C at the Crossroad of Mutations, Cancer, Targeted Therapy and Immune Response.处于突变、癌症、靶向治疗和免疫反应交叉点的蛋白激酶C
Biology (Basel). 2023 Jul 26;12(8):1047. doi: 10.3390/biology12081047.
5
An ErbB Lineage Co-Regulon Harbors Potentially Co-Druggable Targets for Multimodal Precision Therapy in Head and Neck Squamous Cell Carcinoma.ErbB 谱系共调控因子蕴藏头颈部鳞状细胞癌多模式精准治疗的潜在共靶标
Int J Mol Sci. 2022 Nov 4;23(21):13497. doi: 10.3390/ijms232113497.
6
Activation of RhoC by regulatory ubiquitination is mediated by LNX1 and suppressed by LIS1.RhoC 的激活受调节性泛素化调节,该过程由 LNX1 介导,并受 LIS1 抑制。
Sci Rep. 2022 Oct 3;12(1):16493. doi: 10.1038/s41598-022-19740-1.
7
Crumbs3 is expressed in oral squamous cell carcinomas and promotes cell migration and proliferation by affecting RhoA activity.面包屑蛋白3在口腔鳞状细胞癌中表达,并通过影响RhoA活性促进细胞迁移和增殖。
Oncol Lett. 2022 Jun;23(6):173. doi: 10.3892/ol.2022.13293. Epub 2022 Apr 13.
8
Predicting 3D Structure, Cross Talks, and Prognostic Significance of in Cervical Cancer.预测宫颈癌中[具体内容未给出]的三维结构、相互作用及预后意义。
Front Oncol. 2022 Jan 3;11:797007. doi: 10.3389/fonc.2021.797007. eCollection 2021.
9
Comprehensive Molecular Landscape of Cetuximab Resistance in Head and Neck Cancer Cell Lines.头颈部癌细胞系中西妥昔单抗耐药的全面分子特征
Cells. 2022 Jan 4;11(1):154. doi: 10.3390/cells11010154.
10
PKCε regulates Rho GTPases and actin cytoskeleton reorganization in non-small cell lung cancer cells.PKCε 调节非小细胞肺癌细胞中的 Rho GTPases 和肌动蛋白细胞骨架重组。
Small GTPases. 2021 May;12(3):202-208. doi: 10.1080/21541248.2019.1684785. Epub 2019 Oct 29.

本文引用的文献

1
RhoC GTPase expression as a potential marker of lymph node metastasis in squamous cell carcinomas of the head and neck.RhoC GTP酶表达作为头颈部鳞状细胞癌淋巴结转移的潜在标志物。
Clin Cancer Res. 2006 Aug 1;12(15):4485-90. doi: 10.1158/1078-0432.CCR-06-0376.
2
Protein kinase C epsilon is a predictive biomarker of aggressive breast cancer and a validated target for RNA interference anticancer therapy.蛋白激酶Cε是侵袭性乳腺癌的一种预测性生物标志物,也是RNA干扰抗癌治疗的一个经过验证的靶点。
Cancer Res. 2005 Sep 15;65(18):8366-71. doi: 10.1158/0008-5472.CAN-05-0553.
3
Hepatocyte growth factor/scatter factor differentially regulates expression of proangiogenic factors through Egr-1 in head and neck squamous cell carcinoma.肝细胞生长因子/分散因子通过早期生长反应因子-1对头颈部鳞状细胞癌中促血管生成因子的表达进行差异性调控。
Cancer Res. 2005 Aug 15;65(16):7071-80. doi: 10.1158/0008-5472.CAN-04-0989.
4
Phosphorylation of serine 188 protects RhoA from ubiquitin/proteasome-mediated degradation in vascular smooth muscle cells.丝氨酸188的磷酸化可保护RhoA免受血管平滑肌细胞中泛素/蛋白酶体介导的降解。
Circ Res. 2005 Jun 10;96(11):1152-60. doi: 10.1161/01.RES.0000170084.88780.ea. Epub 2005 May 12.
5
PKC controls HGF-dependent c-Met traffic, signalling and cell migration.蛋白激酶C控制HGF依赖的c-Met转运、信号传导及细胞迁移。
EMBO J. 2004 Oct 1;23(19):3721-34. doi: 10.1038/sj.emboj.7600396. Epub 2004 Sep 23.
6
Metastatic squamous cell carcinoma cells that overexpress c-Met exhibit enhanced angiogenesis factor expression, scattering and metastasis in response to hepatocyte growth factor.过表达c-Met的转移性鳞状细胞癌细胞在对肝细胞生长因子的反应中表现出增强的血管生成因子表达、细胞分散和转移。
Oncogene. 2004 Aug 19;23(37):6199-208. doi: 10.1038/sj.onc.1207851.
7
Cell migration: integrating signals from front to back.细胞迁移:整合从前到后的信号。
Science. 2003 Dec 5;302(5651):1704-9. doi: 10.1126/science.1092053.
8
Protein kinase Calpha-induced p115RhoGEF phosphorylation signals endothelial cytoskeletal rearrangement.蛋白激酶Cα诱导的p115RhoGEF磷酸化信号传导内皮细胞骨架重排。
J Biol Chem. 2003 Aug 1;278(31):28793-8. doi: 10.1074/jbc.M303900200. Epub 2003 May 16.
9
RHO-GTPases and cancer.RHO鸟苷三磷酸酶与癌症
Nat Rev Cancer. 2002 Feb;2(2):133-42. doi: 10.1038/nrc725.
10
Neck disease and distant metastases.颈部疾病与远处转移
Oral Oncol. 2003 Apr;39(3):207-12. doi: 10.1016/s1368-8375(02)00049-0.